Celldex Therapeutics, Inc. CLDX
28.27 USD -1.66 (-5.55%)
At closeNov 5, 2026, 4:00 PM EST
28.35 +0.08 +0.28%
After hours · Nov 5, 4:00 PM ET
28.21 Day range 30.00
22.10 52-week range 45.14
- YTD
- +4.09%
- 1 year
- +19.13%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.54M | 7.02M | 6.88M | 2.36M | 4.65M | |
| 1.54M | 7.02M | 6.88M | 2.36M | 4.65M | |
| -287.37M | -195.08M | -154.54M | -122.10M | -72.65M | |
| -258.76M | -157.86M | -141.43M | -112.33M | -70.51M | |
| -3.90 | -2.45 | -2.92 | -2.40 | -1.64 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.87M | 28.36M | 34.81M | 29.43M | 39.14M | |
| 582.98M | 792.34M | 465.63M | 352.74M | 444.65M | |
| 55.82M | 45.34M | 36.46M | 26.53M | 25.18M | |
| 2.34M | 3.81M | 2.54M | 4.03M | 3.04M | |
| 527.16M | 747.00M | 429.17M | 326.20M | 419.48M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -210.94M | -157.78M | -107.29M | -103.73M | -60.91M | |
| 209.07M | -290.13M | -105.78M | 89.94M | -216.16M | |
| 2.39M | 441.45M | 218.46M | 4.08M | 272.37M | |
| -2.71M | -1.92M | -1.82M | -1.76M | -1.22M | |
| 515.00K | -6.46M | 5.38M | -9.71M | -4.69M |